Bristol-Myers Squibb, Vice President Strategic Transactions

President and Chief Executive Officer, Celldex Therapeutics Read more »

Amicus Therapeutics, Inc., Chairman & Chief Executive Officer

Mr. Crowley presently serves as the Chairman and CEO of Amicus. He became CEO in 2005 and was named Chairman in February 2010. Read more »

Chromocell, CEO

Christian Kopfli, Esq., serves as the CEO of Chromocell. From 1998 to 2003, Christian was an associate at Davis Polk & Wardwell in New York City Read more »

Savient Pharmaceuticals, Chief Executive Officer

John H. Johnson has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. Read more »

Vicus Therapeutics, President and CEO

John W. Maki serves as President and CEO of Vicus Therapeutics, LLC. He previously served as Managing Director of Technology Directors, Read more »

Unigene Laboratories; Director

Marvin L. Miller has a broad background in senior management of health care enterprises, including biotechnology, pharmaceuticals, in vitro diagnostics, clinical laboratory Read more »

CardioVax, Chief Executive Officer

Dr. Olukotun is the Chief Executive Officer of CardioVax Inc., a biotechnology company focused on developing innovative cardiovascular therapies. Read more »

PTC Therapeutics, Inc., President and CEO

Dr. Peltz founded PTC Therapeutics, Inc. in 1998 and has been the company’s President and CEO leading all activities from research to fund raising. Read more »

Elusys Therapeutics, Inc., President and CEO

Elizabeth Posillico, Ph.D. joined Elusys in 2002 as Vice President of Business Development and since then moved to take on more management responsibilities of the company Read more »

Johnson & Johnson, Worldwide Vice President, Biopharmaceutical Public Policy and Advocacy

Gary Reedy serves as Worldwide Vice President, Biopharmaceutical Public Policy and Advocacy with Johnson & Johnson, the world’s most comprehensive healthcare manufacturer. Read more »

Cyclacel Pharmaceuticals, Inc., President & CEO

Spiro Rombotis, President and Chief Executive Officer of Cyclacel Pharmaceuticals, Inc. (Berkeley Heights, NJ and Dundee, Scotland), joined the company in August 1997 as the founding CEO.  He has over 27 years of experience with pharmaceutical and biotechnology companies.   Read more »

Previously, James was CEO and President of Tobira Therapeutics, a Manalapan, NJ- based biopharmaceutical company developing novel compounds for HIV/AIDS and inflammatory diseases.  There he brought his 26 years of pharmaceutical experience, 20 years of management experience and 21 years of Infectious Disease specialty focus. Read more »

Drais Pharmaceuticals, Chief Executive Officer and Co-Founder

Dr. Tempel is President, Chief Executive Officer and co-founder of Drais Pharmaceuticals Inc.  Drais is a venture-capital supported clinical drug development company, based in Bridgewater, New Jersey. Read more »